about
Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDTElevated CAIX Expression is Associated with an Increased Risk of Distant Failure in Early-Stage Cervical CancerEpidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacyTumor bioengineering using a transglutaminase crosslinked hydrogelIn vivo photoacoustic lifetime imaging of tumor hypoxia in small animals.Redox- and hypoxia-responsive MRI contrast agents.Phosphorescent oxygen sensor with dendritic protection and two-photon absorbing antenna.Selective delivery of therapeutic agents for the diagnosis and treatment of cancer.Rapid Multi-Tracer PET Tumor Imaging With F-FDG and Secondary Shorter-Lived TracersSolid MRI contrast agents for long-term, quantitative in vivo oxygen sensing.Recent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology.18F-fluromisonidazole PET imaging as a biomarker for the response to 5,6-dimethylxanthenone-4-acetic acid in colorectal xenograft tumors.Molecular imaging of metastatic potential.Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PETDelivery-corrected imaging of fluorescently-labeled glucose reveals distinct metabolic phenotypes in murine breast cancerNon-invasive, simultaneous quantification of vascular oxygenation and glucose uptake in tissue.Specific recommendations for accurate and direct use of PET-CT in PET guided radiotherapy for head and neck sites.Photoacoustic lifetime imaging for direct in vivo tissue oxygen monitoring.RETRACTED: PET imaging of tumour hypoxia.Imaging oxygenation of human tumours.Positron emission tomography: clinical applications in oncology. Part 1.Targeted molecular imaging in oncology: focus on radiation therapy.Image-guided radiation therapy: current and future directions.In vivo models of angiogenesis.Novel imaging approaches to head and neck cancerEvaluation of rapid dual-tracer (62)Cu-PTSM + (62)Cu-ATSM PET in dogs with spontaneously occurring tumors.Strategies To Assess Hypoxic/HIF-1-Active Cancer Cells for the Development of Innovative Radiation Therapy.Monitoring Tumor Hypoxia Using (18)F-FMISO PET and Pharmacokinetics Modeling after Photodynamic Therapy.A novel technology for the imaging of acidic prostate tumors by positron emission tomography.Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.Methodology for quantitative rapid multi-tracer PET tumor characterizationsAdvances in quantitative UV-visible spectroscopy for clinical and pre-clinical application in cancer.Examining the relationship between Cu-ATSM hypoxia selectivity and fatty acid synthase expression in human prostate cancer cell lines.Targeting the hypoxia-inducible factor (HIF) pathway in cancer.Opportunities and pitfalls of cancer imaging in clinical trials.Positron emission tomography radiotracers for imaging hypoxia.Oxygen-Sensing Methods in Biomedicine from the Macroscale to the Microscale.2-(ω-Carboxyethyl)pyrrole Antibody as a New Inhibitor of Tumor Angiogenesis and Growth.A robotic system for F18-FMISO PET-guided intratumoral pO2 measurements.Quantification of Tumor Hypoxic Fractions Using Positron Emission Tomography with [18F]Fluoromisonidazole ([18F]FMISO) Kinetic Analysis and Invasive Oxygen Measurements.
P2860
Q27324380-94A78141-8964-42B3-889D-F05FF17A1600Q28250852-B8E624D7-F916-41C4-BF0E-0DACC2D70999Q28475894-F015C726-5EF4-40E4-B9D6-8F74A51C0B7FQ28542066-F983F80B-4917-4C30-B58F-BDCB81F05811Q30434454-097913CD-7C17-4FC0-AD30-645DF526EB61Q30820031-F1E5B1DA-E96B-46B9-AA7E-B7F8266FB94FQ33221821-670E58FF-D320-45BD-8A53-42EB8E8FA091Q33230098-5FB4F0CA-5AB5-485F-8B36-32DF96929377Q33562307-2CB979FC-6465-44A9-A23D-AD2C9AD41450Q33607091-7A265259-97DC-4BF8-9B66-B9658925176AQ33669828-6EF27E7C-9C86-4A68-8686-D2D842299E46Q33820595-13AA246E-379E-4A66-9A1E-385F31B2E5DBQ33917943-9A6C76C5-4ADB-458E-A8FF-E042FAA530EEQ34235986-1123F829-5D24-4988-9103-5C9120C1E786Q34744489-20D0A07B-981F-4AE5-9526-7BD7CD8AB25AQ35031920-CB6715BE-B304-49B6-BA9F-C34D150E4624Q35138065-1E01D365-66E4-44AF-AE6F-B8BDDF36033FQ35153619-CC73F325-1513-45E9-A2C0-9AAD32390B8EQ35650691-1503C406-A830-464B-A222-8EE1BE21F4E4Q35676947-E688A1F7-6B2F-4F52-8AE4-4C7749D54114Q36334917-0E5AFD24-3D89-42BF-A2CF-C7371F4F96E0Q36528175-5810C281-5C6E-47FE-A468-9BFD83E6FCF3Q36572525-28B9FBF2-282B-4E70-9B02-71122F8B87A0Q36600421-02631ADF-D7D6-4E4F-95DD-BE2B991A7142Q37012938-F02CB2BC-E070-44EB-BE2C-2364561DB0DEQ37102927-95D30A0F-A299-4C3B-8ED8-C9400D4BF145Q37137456-0C2F3730-E44E-49F8-BB23-F3CA94EBB3D4Q37193204-9000E23B-491E-4997-A8C3-AD1123F96325Q37213034-2004576C-2411-4043-A07E-E5BB86A16235Q37236103-E7A39EF9-A868-4DBB-B810-A3A80624B16AQ37342653-C1C6FC88-45A8-49C5-8ED8-714BF92AF494Q37344219-EEC6AEC2-026B-4B20-B37D-84644CDBE225Q37414432-33B50A02-1C8E-47B6-9191-DBE4B3C2E52CQ37587446-DB862F77-10BC-4EDF-BCF0-90159A9D7BFBQ37869334-A5ACB096-7FB5-43FF-A5DA-C21F80BB6A59Q38166980-F16F9B32-66E4-44B4-A08B-8CFE8390C05BQ38530352-CA506FA0-51E0-4A08-9400-0EC6C9677062Q38743607-C93CA44C-0AA0-4F4C-B89D-2BF690111FCAQ38774781-C3D21A3B-F882-4350-8D4A-D0F6896708DFQ38837272-D6C8EC2F-6BC8-4B5E-A2D6-49F18389C8FF
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Imaging hypoxia and angiogenesis in tumors.
@ast
Imaging hypoxia and angiogenesis in tumors.
@en
type
label
Imaging hypoxia and angiogenesis in tumors.
@ast
Imaging hypoxia and angiogenesis in tumors.
@en
prefLabel
Imaging hypoxia and angiogenesis in tumors.
@ast
Imaging hypoxia and angiogenesis in tumors.
@en
P1476
Imaging hypoxia and angiogenesis in tumors.
@en
P2093
Joseph G Rajendran
Kenneth A Krohn
P304
P356
10.1016/J.RCL.2004.08.004
P577
2005-01-01T00:00:00Z